CorriXR Therapeutics Information
Contact top employees from
CorriXR Therapeutics
Summary
CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative pre-clinical stage biotechnology company with a ground-breaking in vivo gene editing therapeutic platform technolog...Show more
Organization Website | corrixr.com |
Social Links |  |
Phone Number | 302-623-5305 |
Industries | |
Headquarters Location | 550 S College Ave, Newark, Delaware, 19713 US |
Employees Size | 1-10 employees |
Founded | 2022 |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2018 | Privately Held | 1 - 25 | 6M | $109.5M | |
| 2020 | - | 1 - 25 | 1.2M | $81M | |
| 2017 | Privately Held | 10-50 | < 1M | $0 | |
| - | - | 1-10 | - | $- |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at CorriXR Therapeutics shows a diverse range of experience levels:
25% have been with the company for less than 1 year50% for 1–2 years25% for 3–4 yearsContact top employees from
CorriXR Therapeutics
Eric Kmiec
Chief Executive Officer
Jennifer Kmiec
Chief of Staff
Jeffrey Carper
Board Member
Similar Companies
FAQ
CorriXR Therapeutics operates in the Biotech industries. More details can be found on the official website: corrixr.com.
The headquarters of CorriXR Therapeutics are located in Newark, United States.
You can contact CorriXR Therapeutics by phone at 302-623-5305.
CorriXR Therapeutics currently employs 1-10 people.
Well-known competitors of CorriXR Therapeutics include Aro Biotherapeutics, Faze Medicines, Cygnal Therapeutics Cambridge, United States and Scout Bio.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
